Acasti Pharma reported 9.94 in PE Price to Earnings for its fiscal quarter ending in March of 2021.





Pe Change Date
Acasti Pharma 9.94 0.08 Mar/2021
Addus HomeCare 15.87 0.26 Sep/2026
Amarin 91.05 88.3 Jun/2023
Knight Therapeutics 257.34 166.24 Dec/2025
Option Care Health 16.38 4.82 Jun/2026
Organigram Holdings 15.55 3.54 Jun/2026
Tilray 11.56 80.19 Sep/2025